1,383 results on '"Kusek, John W."'
Search Results
152. Catastrophizing and Pain-Contingent Rest Predict Patient Adjustment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
153. Effect of Dietary Protein Restriction on the Progression of Kidney Disease: Long-Term Follow-Up of the Modification of Diet in Renal Disease (MDRD) Study
154. Quality of Life in the African American Study of Kidney Disease and Hypertension: Effects of Blood Pressure Management
155. Hemodialysis Timing, Survival, and Cardiovascular Outcomes in the Hemodialysis (HEMO) Study
156. Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo
157. Effect of dialysis dose and membrane flux in maintenance hemodialysis
158. Retinopathy and Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort (CRIC) Study
159. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
160. Inadequacy of cardiovascular risk factor management in chronic kidney transplantation – evidence from the FAVORIT study
161. A Randomized Trial of Urodynamic Testing before Stress-Incontinence Surgery
162. Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial
163. Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
164. Use of Aspirin Associates with Longer Primary Patency of Hemodialysis Grafts
165. Demographic and Clinical Predictors of Treatment Failure One Year After Midurethral Sling Surgery
166. The Association of Adiposity and Overactive Bladder Appears to Differ by Gender: Results From the Boston Area Community Health Survey
167. Early Termination of a Trial of Mycophenolate Mofetil for Treatment of Interstitial Cystitis/Painful Bladder Syndrome: Lessons Learned
168. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study
169. Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD
170. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study
171. Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients
172. Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular Disease
173. Pregabalin for the Treatment of Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial
174. Effect of Weight Loss on Urinary Incontinence in Overweight and Obese Women: Results at 12 and 18 Months
175. Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
176. Effect of Amitriptyline on Symptoms in Treatment Naïve Patients With Interstitial Cystitis/Painful Bladder Syndrome
177. Chronic Kidney Disease and Cognitive Function in Older Adults: Findings from the Chronic Renal Insufficiency Cohort Cognitive Study
178. Urological Complications of Obesity and Diabetes
179. A New Equation to Estimate Glomerular Filtration Rate
180. Poster Board #-Session: P170-I Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.: Abstract# 827
181. THE UTILITY OF ULTRASOUND DERIVED PROSTATE PARAMETERS IN PREDICTING CLINICAL RESPONSE IN MEN TREATED WITH BOTULINUM NEUROTOXIN TYPE A (BONT-A) FOR BENIGN PROSTATIC HYPERPLASIA (BPH): 1802
182. 12-WEEK RESULTS OF A PHASE II TRIAL OF 100 AND 300 UNITS BOTULINUM NEUROTOXIN TYPE A (BONT-A) FOR THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH): 1800
183. A RANDOMIZED PLACEBO-CONTROLLED MULTICENTER TRIAL OF PREGABALIN FOR THE TREATMENT OF MEN WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: 340
184. COMPARISON OF SYMPTOMS IN NEWLY-DIAGNOSED VS CHRONIC-REFRACTORY PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS): 335
185. Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study
186. Urinary Incontinence Among Women With Type 1 Diabetes—How Common is it?
187. A RANDOMIZED CONTROLLED TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR TREATMENT REFRACTORY INTERSTITIAL CYSTITIS
188. Long-Term Treatment With Finasteride Results in a Clinically Significant Reduction in Total Prostate Volume Compared to Placebo Over the Full Range of Baseline Prostate Sizes in Men Enrolled in the MTOPS Trial
189. The Influence of Age on Changes in Health-Related Quality of Life over Three Years in a Cohort Undergoing Hemodialysis
190. Behavioral Therapy to Enable Women with Urge Incontinence to Discontinue Drug Treatment: A Randomized Trial
191. The Relationship of Common Medical Conditions and Medication Use With Symptoms of Painful Bladder Syndrome: Results From the Boston Area Community Health Survey
192. Prevalence and Psychosocial Correlates of Symptoms Suggestive of Painful Bladder Syndrome: Results From the Boston Area Community Health Survey
193. Long-term Effects of Renin-Angiotensin System–Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans
194. LONG-TERM TREATMENT WITH FINASTERIDE RESULTED IN A SIGNIFICANT REDUCTION IN TOTAL PROSTATE VOLUME COMPARED TO PLACEBO ACROSS THE FULL RANGE OF BASELINE TOTAL PROSTATE VOLUMES IN MEN ENROLLED IN THE MEDICAL THERAPY OF PROSTATIC SYMPTOMS (MTOPS) TRIAL: 2032
195. THE EFFECT OF SURGERY FOR STRESS URINARY INCONTINENCE ON QUALITY OF LIFE IN WOMEN ENROLLED IN A RANDOMIZED CLINICAL TRIAL COMPARING THE BURCH AND SLING PROCEDURES: 312
196. A RANDOMIZED MULTICENTER DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ALFUZOSIN IN THE TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS) IN RECENTLYDIAGNOSED AND/OR NEWLY-SYMPTOMATIC ALPHA-BLOCKER NAIVE PATIENTS: 87
197. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study
198. Did Patients With Interstitial Cystitis Who Failed to Respond to Initial Treatment With Bacillus Calmette-Guerin or Placebo in a Randomized Clinical Trial Benefit From a Second Course of Open Label Bacillus Calmette-Guerin?
199. The Contribution of Common Medical Conditions and Drug Exposures to Erectile Dysfunction in Adult Males
200. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.